Neuroendocrine pancreatic tumors: Guidelines for management and update

Current Treatment Options in Oncology

Volumn 13, Issue 1, 2012, Pages 24-34

  Burns, William R ^a   Edil, Barish H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Islet cell tumors; Multiple endocrine neoplasia type 1 (MEN 1); Neoplasms; Neuroendocrine pancreatic tumors; Pancreatectomy; Pancreatic endocrine hormones; PanNETs; von Hippel Lindau (VHL)

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CHROMOGRANIN A; CISPLATIN; DACARBAZINE; DIAZOXIDE; DOXORUBICIN; ETOPOSIDE; EVEROLIMUS; FLUOROURACIL; GASTRIN; GLUCAGON; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MELPHALAN; OCTREOTIDE; OXALIPLATIN; PLACEBO; PLATELET DERIVED GROWTH FACTOR; STREPTOZOCIN; SUNITINIB; TEMOZOLOMIDE; VASCULOTROPIN; YTTRIUM 90;

ADVANCED CANCER; BILE LEAKAGE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CARCINOGENESIS; CHEMOEMBOLIZATION; CYTOREDUCTIVE SURGERY; GASTRINOMA; HUMAN; HYPERINSULINISM; INSULINOMA; LIVER METASTASIS; LONG TERM SURVIVAL; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS DUCT STENOSIS; PANCREAS FISTULA; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; PANCREATICODUODENECTOMY; PEPTIC ULCER; PEROPERATIVE ECHOGRAPHY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; REVIEW; SOLID TUMOR; SPLENECTOMY; TUMOR LOCALIZATION; UNSPECIFIED SIDE EFFECT; VON HIPPEL LINDAU DISEASE;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; NEOPLASTIC SYNDROMES, HEREDITARY; NEUROENDOCRINE TUMORS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SOMATOSTATIN;

EID: 84857658992     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-011-0172-2     Document Type: Review

References (50)

1. JC Yao M Hassan A Phan, et al. 2008 One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 3063 3072 18565894 10.1200/JCO.2007.15.4377
2. MT Carriaga DE Henson 1995 Liver, gallbladder, extrahepatic bile ducts, and pancreas Cancer 75 171 190 8000995 10.1002/1097-0142(19950101)75:1+<171:: AID-CNCR2820751306>3.0.CO;2-2 1:STN:280:DyaK2M%2FpsVWhsg%3D%3D
3. TR Halfdanarson KG Rabe J Rubin GM Petersen 2008 Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival Ann Oncol 19 1727 1733 18515795 10.1093/annonc/mdn351 1:STN:280:DC%2BD1cnhslKnsA%3D%3D
4. L Grimelius GT Hultquist B Stenkvist 1975 Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material Virchows Arch A Pathol Anat Histol 365 275 288 46649 10.1007/BF00471177 1:STN:280: DyaE2M7gsVagtA%3D%3D
5. W Kimura A Kuroda Y Morioka 1991 Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases Dig Dis Sci 36 933 942 2070707 10.1007/BF01297144 1:STN:280:DyaK3MzgtV2ksQ%3D%3D
6. AG Pearse 1980 The APUD concept and hormone production Clin Endocrinol Metab 9 211 222 6105028 10.1016/S0300-595X(80)80030-2 1:CAS:528: DyaL3cXls1Gntrs%3D (Pubitemid 10005339)
7. BS Wilson RV Lloyd 1984 Detection of chromogranin in neuroendocrine cells with a monoclonal antibody Am J Pathol 115 458 468 6375394 1:STN:280: DyaL2c3ivVOltw%3D%3D (Pubitemid 14121197)
8. B Wiedenmann WW Franke C Kuhn, et al. 1986 Synaptophysin: a marker protein for neuroendocrine cells and neoplasms Proc Natl Acad Sci U S A 83 3500 3504 3010302 10.1073/pnas.83.10.3500 1:CAS:528:DyaL28XktVCnsrg%3D (Pubitemid 16051994)
9. FJ Tapia JM Polak AJ Barbosa, et al. 1981 Neuron-specific enolase is produced by neuroendocrine tumours Lancet 317 808 811 10.1016/S0140-6736(81) 92682-9 (Pubitemid 11147436)
10. AO Vortmeyer S Huang I Lubensky Z Zhuang 2004 Non-islet origin of pancreatic islet cell tumors J Clin Endocrinol Metab 89 1934 1938 15070966 10.1210/jc.2003-031575 1:CAS:528:DC%2BD2cXjt1eltb8%3D (Pubitemid 38507955)
11. Y Jiao C Shi BH Edil, et al. 2011 DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors Science 331 1199 1203 21252315 10.1126/science.1200609 1:CAS:528:DC%2BC3MXislOku70%3D This study explores the genetic basis of PanNETs, identifying three frequently disrupted molecular pathways.
12. N Alexakis S Connor P Ghaneh, et al. 2004 Hereditary pancreatic endocrine tumours Pancreatology 4 417 433 15249710 10.1159/000079616 1:STN:280: DC%2BD2cvgtFOksg%3D%3D (Pubitemid 39140441)
13. SN Hochwald S Zee KC Conlon, et al. 2002 Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups J Clin Oncol 20 2633 2642 12039924 10.1200/JCO.2002.10.030 (Pubitemid 34575635)
14. Heitz PU, Komminoth P, Perren A, et al. Pancreatic endocrine tumours. In: DeLellis R, Lloyd R, Heitz PU, et al., editors. World Health Organization classification of tumors pathology and genetics of tumors of endocrine organs. Lyon: IARC; 2004. p. 177-82.
15. G Rindi G Klöppel H Alhman, et al. 2006 TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Virchows Arch 449 395 401 16967267 10.1007/s00428-006-0250-1 1:STN:280:DC%2BD28rmtlGntA%3D%3D (Pubitemid 44451313)
16. Edge SB. Exocrine and endocrine pancreas. In: Edge SB, editor. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
17. MH Kulke LL Siu JE Tepper, et al. 2011 Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting J Clin Oncol 29 934 943 21263089 10.1200/JCO.2010.33.2056 1:CAS:528:DC%2BC3MXktlelsbo%3D This consensus report details key recommendations for future trials evaluating patients with neuroendocrine tumors.
18. F Gibril RT Jensen 2004 Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours Dig Liver Dis 36 Suppl 1 S106 S120 15077919 10.1016/j.dld.2003.11.024 1:CAS:528: DC%2BD2cXjsFOns7w%3D (Pubitemid 41115498)
19. T Rösch CJ Lightdale JF Botet, et al. 1992 Localization of pancreatic endocrine tumors by endoscopic ultrasonography N Engl J Med 326 1721 1726 1317506 10.1056/NEJM199206253262601
20. MA Khashab E Yong AM Lennon, et al. 2011 EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors Gastrointest Endosc 73 691 696 21067742 10.1016/j.gie.2010.08.030 This retrospective study demonstrates the utility of EUS in detecting PanNETs, especially insulinomas and those tumors not identified by CT scan.
21. JL Doppman DL Miller R Chang, et al. 1991 Insulinomas: localization with selective intraarterial injection of calcium Radiology 178 237 241 1984311 1:STN:280:DyaK3M%2FnsV2rtQ%3D%3D
22. JM Guettier A Kam R Chang, et al. 2009 Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience J Clin Endocrinol Metab 94 1074 1080 19190102 10.1210/jc.2008-1986 1:CAS:528:DC%2BD1MXksFaitr4%3D
23. JA Sosa HM Bowman TA Gordon, et al. 1998 Importance of hospital volume in the overall management of pancreatic cancer Ann Surg 228 429 438 9742926 10.1097/00000658-199809000-00016 1:STN:280:DyaK1cvhtlymug%3D%3D (Pubitemid 30191706)
24. DJ Waghorn 2001 Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed J Clin Pathol 54 214 218 11253134 10.1136/jcp.54.3.214 1:STN:280:DC%2BD3M7osFartA%3D%3D (Pubitemid 32205043)
25. SC Mayo MC de Jong C Pulitano, et al. 2010 Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis Ann Surg Oncol 17 3129 3136 20585879 10.1245/s10434-010-1154-5 This study details the outcomes of patients with metastatic neuroendocrine tumors who undergo liver-directed surgery.
26. JM Sarmiento FG Que CS Grant, et al. 2002 Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach Surgery 132 976 982 12490844 10.1067/msy.2002.128615 (Pubitemid 36026944)
27. MC De Jong MB Farnell G Sclabas, et al. 2010 Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis Ann Surg 252 142 148 20531007 10.1097/SLA.0b013e3181dbb7a7 This study details the substantial morbidity associated with liver-directed therapy in a cohort of patients who underwent pancreaticoduodenectomy. It also identified a significant increase in liver abscess among those patients who received interval, as opposed to simultaneous, liver-directed therapy.
28. T Steinmüller R Kianmanesh M Falconi, et al. 2008 Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary Neuroendocrinology 87 47 62 18097131 10.1159/000111037 (Pubitemid 350308294)
29. T Lehnert 1998 Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients Transplantation 66 1307 1312 9846513 10.1097/00007890-199811270-00007 1:STN:280:DyaK1M%2FmtV2ntQ%3D%3D (Pubitemid 28551010)
30. DC Madoff S Gupta K Ahrar, et al. 2006 Update on the management of neuroendocrine hepatic metastases J Vasc Interv Radiol 17 1235 1249 16923972 10.1097/01.RVI.0000232177.57950.71 (Pubitemid 44259008)
31. S Gupta MM Johnson R Murthy, et al. 2005 Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 1590 1602 16134179 10.1002/cncr.21389 (Pubitemid 41437421)
32. HY Akyildiz J Mitchell M Milas, et al. 2010 Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up Surgery 148 1288 1293 21134563 10.1016/j.surg.2010.09.014
33. H Ahmadzadehfar HJ Biersack S Ezziddin 2010 Radioembolization of liver tumors with yttrium-90 microspheres Semin Nucl Med 40 105 121 20113679 10.1053/j.semnuclmed.2009.11.001
34. AS Kennedy WA Dezarn P McNeillie, et al. 2008 Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients Am J Clin Oncol 31 271 279 18525307 10.1097/COC.0b013e31815e4557
35. N Miao JF Pingpank HR Alexander, et al. 2008 Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations Ann Surg Oncol 15 815 823 18180999 10.1245/s10434-007-9781-1
36. K Oberg L Kvols M Caplin, et al. 2004 Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system Ann Oncol 15 966 973 15151956 10.1093/annonc/ mdh216 1:STN:280:DC%2BD2c3lt12jug%3D%3D (Pubitemid 39004355)
37. A Rinke HH Müller C Schade-Brittinger, et al. 2009 Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group J Clin Oncol 27 4656 4663 19704057 10.1200/JCO.2009.22.8510 1:CAS:528:DC%2BD1MXhtlGgtbnJ This randomized control trial of a long-acting somatostatin analogue (octreotide LAR) compared to placebo demonstrated prolonged time to progression in patients with neuroendocrine tumors.
38. CG Moertel M Lefkopoulo S Lipsitz, et al. 1992 Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma N Engl J Med 326 519 523 1310159 10.1056/ NEJM199202203260804 1:STN:280:DyaK387itlejuw%3D%3D
39. CG Moertel LK Kvols MJ O'Connell J Rubin 1991 Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms Cancer 68 227 232 1712661 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I 1:STN:280:DyaK3MzgtVCjuw%3D%3D
40. MH Kulke HJ Lenz NJ Meropol, et al. 2008 Activity of sunitinib in patients with advanced neuroendocrine tumors J Clin Oncol 26 3403 3410 18612155 10.1200/JCO.2007.15.9020 1:CAS:528:DC%2BD1cXpvVWitro%3D
41. E Raymond L Dahan JL Raoul, et al. 2011 Sunitinib malate for the treatment of pancreatic neuroendocrine tumors N Engl J Med 364 501 513 21306237 10.1056/NEJMoa1003825 1:CAS:528:DC%2BC3MXhvVyisrY%3D This randomized control trial favored sunitinib, as compared to placebo, for patients with advanced well-differentiated PanNET in terms of response rate and progression-free survival.
42. JC Yao AT Phan DZ Chang, et al. 2008 Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II trial J Clin Oncol 26 4311 4318 18779618 10.1200/JCO.2008.16.7858
43. JC Yao C Lombard-Bohas E Baudin, et al. 2010 Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial J Clin Oncol 28 69 76 19933912 10.1200/JCO.2009.24.2669 1:CAS:528:DC%2BC3cXhtF2rsr4%3D
44. JC Yao MH Shah T Ito, et al. 2011 Everolimus for advanced pancreatic neuroendocrine tumors N Engl J Med 364 514 523 21306238 10.1056/NEJMoa1009290 1:CAS:528:DC%2BC3MXhvVyiu7s%3D This randomized control trial of everolimus compared to placebo for patients with progressive, advanced PanNET demonstrated an improvement in median progression-free survival.
45. PL Kunz T Kuo JM Zahn, et al. 2010 A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors J Clin Oncol 28 15 Suppl 4104
46. AO Whipple VK Frantz 1935 Adenoma of islet cells with hyperinsulinism: a review Ann Surg 101 1299 1335 17856569 10.1097/00000658-193506000-00001 1:STN:280:DC%2BD2srktFKguw%3D%3D
47. E Finlayson OH Clark 2004 Surgical treatment of insulinomas Surgical Clin North Am 84 775 785 10.1016/j.suc.2004.02.004 (Pubitemid 38622416)
48. SS Fajans AI Vinik 1989 Insulin-producing islet cell tumors Endocrinol Metab Clin North Am 18 45 74 2537193 1:STN:280:DyaL1M7jslSnsQ%3D%3D (Pubitemid 19058101)
49. RM Zollinger EH Ellison 1955 Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas Ann Surg 142 709 723 13259432 10.1097/00000658-195510000-00015 1:STN:280:DyaG28%2FhtFegtg%3D%3D
50. TJ Howard BE Stabile MJ Zinner, et al. 1990 Anatomic distribution of pancreatic endocrine tumors Am J Surg 159 258 264 2154144 10.1016/S0002-9610(05) 80276-4 1:STN:280:DyaK3c7ksFelug%3D%3D (Pubitemid 20057932)